People | January 10, 2023
GenNext Technologies appoints Dr. John Grant to its Board of Directors
Dr. Grant brings to the table significant BOD governance, global business development, and corporate development expertise
Dr. Grant brings to the table significant BOD governance, global business development, and corporate development expertise
To create leading company developing medicines targeting metalloenzymes
The company continue to develop this program for the WHO markets, thereby providing coverage and protection for more infants globally in time to come
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
The MOU will involve product collaboration from both companies with a goal of propelling PFAS destruction in groundwater globally
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
The joint venture will help both the parties to further develop the high-margin service business
Acquisition expands Merck’s growing hematology portfolio
Zydus becomes the only Indian oncology player to venture into prognosis and diagnosis along with treatment planning
The company is making its entry into the Hyderabad market through its unique asset-light business model
Subscribe To Our Newsletter & Stay Updated
